Page last updated: 2024-08-23

simvastatin and omacor

simvastatin has been researched along with omacor in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatnagar, D; Durrington, PN; France, M; Julier, K; Khan, MA; Mackness, MI; Morgan, J1
Nordøy, A1
Ballantyne, CM; Bays, HE; Davidson, MH; Doyle, RT; Ginsberg, HN; Maki, KC; Shalwitz, RA; Stein, EA1
Kang, HJ; Kim, HS; Kim, MK; Kim, SH; Kim, YJ; Lee, HY1

Reviews

1 review(s) available for simvastatin and omacor

ArticleYear
Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.
    Minerva medica, 2002, Volume: 93, Issue:5

    Topics: Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Diet; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Exercise; Fatty Acids, Omega-3; Heptanoic Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin

2002

Trials

3 trial(s) available for simvastatin and omacor

ArticleYear
An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.
    Heart (British Cardiac Society), 2001, Volume: 85, Issue:5

    Topics: Adult; Aged; Cholesterol; Coronary Disease; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Simvastatin; Triglycerides

2001
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Clinical therapeutics, 2007, Volume: 29, Issue:7

    Topics: Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Male; Middle Aged; Simvastatin

2007
Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipoprotein profiles and heart rate variability.
    European journal of clinical nutrition, 2011, Volume: 65, Issue:1

    Topics: Adult; Aged; Asian People; Cholesterol; Dietary Supplements; Docosahexaenoic Acids; Drug Combinations; Drug Therapy, Combination; Dyslipidemias; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Heart Rate; Humans; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Prospective Studies; Republic of Korea; Simvastatin; Triglycerides

2011
chemdatabank.com